{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:46:23Z","timestamp":1782729983173,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04979-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:55:01Z","timestamp":1778003701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report of adult-type diffuse high-grade glioma IDH-wildtype subtype E with secondary spinal leptomeningeal dissemination, prolonged survival and literature review"],"prefix":"10.1007","volume":"17","author":[{"given":"Ad\u00e8le","family":"Meola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Testud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Petrirena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Barri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Autran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaissar","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pougnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Tabouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Harlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"8","key":"4979_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro Oncol"},{"issue":"7697","key":"4979_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u201374. https:\/\/doi.org\/10.1038\/nature26000.","journal-title":"Nature"},{"issue":"11","key":"4979_CR3","doi-asserted-by":"publisher","first-page":"e1763","DOI":"10.1634\/theoncologist.2020-0258","volume":"25","author":"C Birzu","year":"2020","unstructured":"Birzu C, Tran S, Bielle F, et al. Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges. Oncologist. 2020;25(11):e1763\u201376. https:\/\/doi.org\/10.1634\/theoncologist.2020-0258.","journal-title":"Oncologist"},{"issue":"3","key":"4979_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, Van Den Bent M, Preusser M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18(3):170\u201386. https:\/\/doi.org\/10.1038\/s41571-020-00447-z.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"4979_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.21873\/anticanres.13210","volume":"39","author":"D Autran","year":"2019","unstructured":"Autran D, Barrie M, Matta M, et al. Leptomeningeal gliomatosis: a single institution study of 31 patients. Anticancer Res. 2019;39(2):1035\u201341. https:\/\/doi.org\/10.21873\/anticanres.13210.","journal-title":"Anticancer Res"},{"issue":"5","key":"4979_CR6","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cell.2017.09.048","volume":"171","author":"BB Campbell","year":"2017","unstructured":"Campbell BB, Light N, Fabrizio D, et al. Comprehensive analysis of hypermutation in human cancer. Cell. 2017;171(5):1042-1056.e10. https:\/\/doi.org\/10.1016\/j.cell.2017.09.048.","journal-title":"Cell"},{"issue":"Supplement_5","key":"4979_CR7","doi-asserted-by":"publisher","first-page":"v172","DOI":"10.1093\/neuonc\/noad179.0653","volume":"25","author":"O Singh","year":"2023","unstructured":"Singh O, Aldape K, Abdullaev Z, et al. PATH-23. Clinicopathologic analysis of novel methylation clusters of idh-wildtype diffuse gliomas. Neuro-Oncol. 2023;25(Supplement_5):v172\u2013v172. https:\/\/doi.org\/10.1093\/neuonc\/noad179.0653.","journal-title":"Neuro-Oncol"},{"issue":"1","key":"4979_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-496","volume":"7","author":"T Linsenmann","year":"2014","unstructured":"Linsenmann T, Monoranu CM, Vince GH, et al. Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report. BMC Res Notes. 2014;7(1):496. https:\/\/doi.org\/10.1186\/1756-0500-7-496.","journal-title":"BMC Res Notes"},{"issue":"8","key":"4979_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jocn.2011.09.024","volume":"19","author":"M Shahideh","year":"2012","unstructured":"Shahideh M, Fallah A, Munoz DG, Loch Macdonald R. Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients. J Clin Neurosci. 2012;19(8):1080\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2011.09.024.","journal-title":"J Clin Neurosci"},{"issue":"12","key":"4979_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/COC.0000000000000434","volume":"41","author":"JJ Timmons","year":"2018","unstructured":"Timmons JJ, Zhang K, Fong J, et al. Literature review of spinal cord glioblastoma. Am J Clin Oncol. 2018;41(12):1281\u20137. https:\/\/doi.org\/10.1097\/COC.0000000000000434.","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"4979_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3109\/00207454.2012.704456","volume":"122","author":"A Fiorentino","year":"2012","unstructured":"Fiorentino A, Caivano R, Chiumento C, Cozzolino M, Fusco V. Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature. Int J Neurosci. 2012;122(11):691\u20134. https:\/\/doi.org\/10.3109\/00207454.2012.704456.","journal-title":"Int J Neurosci"},{"issue":"3","key":"4979_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11060-010-0330-6","volume":"102","author":"MC Chamberlain","year":"2011","unstructured":"Chamberlain MC, Johnston SK. Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab. J Neurooncol. 2011;102(3):427\u201332. https:\/\/doi.org\/10.1007\/s11060-010-0330-6.","journal-title":"J Neurooncol"},{"issue":"2","key":"4979_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11060-012-0905-5","volume":"109","author":"TJ Kaley","year":"2012","unstructured":"Kaley TJ, Mondesire-Crump I, Gavrilovic IT. Temozolomide or bevacizumab for spinal cord high-grade gliomas. J Neurooncol. 2012;109(2):385\u20139. https:\/\/doi.org\/10.1007\/s11060-012-0905-5.","journal-title":"J Neurooncol"},{"issue":"6","key":"4979_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155315","volume":"11","author":"MC Burger","year":"2016","unstructured":"Burger MC, Zeiner PS, Jahnke K, Wagner M, Mittelbronn M, Steinbach JP. Addition of anti-angiogenetic therapy with bevacizumab to chemo- and radiotherapy for leptomeningeal metastases in primary brain tumors. PLoS ONE. 2016;11(6):e0155315. https:\/\/doi.org\/10.1371\/journal.pone.0155315.","journal-title":"PLoS ONE"},{"issue":"2","key":"4979_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5455\/aim.2014.22.142-144","volume":"22","author":"G Kaloshi","year":"2014","unstructured":"Kaloshi G, Roji A, Seferi A, et al. Spinal dissemination of intracranial glioblastoma in bevacizumab era: a potential bevacizumab-induced mechanism. Acta Inform Med. 2014;22(2):142. https:\/\/doi.org\/10.5455\/aim.2014.22.142-144.","journal-title":"Acta Inform Med"},{"issue":"3","key":"4979_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12328-023-01761-6","volume":"16","author":"N Odagiri","year":"2023","unstructured":"Odagiri N, Tamori A, Kotani K, et al. A case of hepatocellular carcinoma with \u201cpseudoprogression\u201d followed by complete response to atezolizumab plus bevacizumab. Clin J Gastroenterol. 2023;16(3):392\u20136. https:\/\/doi.org\/10.1007\/s12328-023-01761-6.","journal-title":"Clin J Gastroenterol"},{"key":"4979_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.812916","volume":"11","author":"S Jain","year":"2022","unstructured":"Jain S, Chalif EJ, Aghi MK. Interactions between anti-angiogenic therapy and immunotherapy in glioblastoma. Front Oncol. 2022;11:812916. https:\/\/doi.org\/10.3389\/fonc.2021.812916.","journal-title":"Front Oncol"},{"key":"4979_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109990","volume":"117","author":"X Huang","year":"2023","unstructured":"Huang X, Shi S, Wang H, et al. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas. Int Immunopharmacol. 2023;117:109990. https:\/\/doi.org\/10.1016\/j.intimp.2023.109990.","journal-title":"Int Immunopharmacol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04979-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:05:05Z","timestamp":1782727505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04979-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4979"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04979-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Ethics Committee of Aix-Marseille University, in accordance with the 1964 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors confirm that written informed consent for study participation was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from the patient for publication of this report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"942"}}